The isotonic solution is intended for inhalation, instillation and rinsing of the nasal cavities. The hyaluronic acid contained in it deeply moisturizes and supports the regeneration of the mucous membrane and protects it from drying out . The product moisturizes the upper and lower respiratory tract, which facilitates the removal of retained secretions . The solution has a relaxing effect, thanks to the hypertonic concentration of sodium chloride.
Action
NEBU-DOSE HIPERTONIC is an inhalation solution that supports the self-cleaning process of the upper and lower respiratory tract.
Thanks to the hypertonic concentration of sodium chloride, the solution has a constrictive effect on the mucous membrane, allowing for easier removal of secretions to the outside.
Additionally, the preparation moisturizes the mucous membrane, making breathing easier.
INDICATIONS:
- acute bronchitis
- bronchiolitis
- Cystic fibrosis
- chronic obstructive pulmonary disease
Composition
Hypertonic sodium chloride solution for inhalation (3% NaCl).
How to use
One ampoule (5 ml) is used for a single inhalation. Inhalation should be performed 2-4 times a day as directed by a physician. Ampoules can be used with any type of inhaler.
Contraindications
Do not use in case of hypersensitivity to sodium chloride.
If the patient is prone to shortness of breath, consult a doctor before use. Single-use ampoule. Do not inject.
Warnings
This is a medical device. Use it according to the instructions for use or label.
Additional information and storage: Sterile single-use ampoules. The ampoule should be used immediately after opening. Do not use after the expiry date. Keep out of reach of children. Store in a dry place below 25°C. Protect from light. Use as intended. For correct use of the solution with the inhaler, follow the instructions for use of the device.
Interactions: If you are using other medications, consult your doctor before use.
Contents: The package contains: 30 ampoules.
Storage method: 15°C – 25°C
Reviews
Clear filtersThere are no reviews yet.